Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Allena Pharmaceuticals (ALNAQ)
OTHER OTC:ALNAQ
Holding ALNAQ?
Track your performance easily
ALNAQ Stock Chart & Stats
Day’s Range<$0.01 - <$0.01
52-Week Range― - ―
Previous Close$0.000001
Volume96.56K
Average Volume (3M)N/A
Market Cap
$122.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ALNAQ FAQ
What was Allena Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Allena Pharmaceuticals’s market cap?
Currently, no data Available
When is Allena Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Allena Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Allena Pharmaceuticals overvalued?
According to Wall Street analysts Allena Pharmaceuticals’s price is currently Overvalued.
Does Allena Pharmaceuticals pay dividends?
Allena Pharmaceuticals does not currently pay dividends.
What is Allena Pharmaceuticals’s EPS estimate?
Allena Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Allena Pharmaceuticals have?
Currently, no data Available
What happened to Allena Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Allena Pharmaceuticals?
Currently, no hedge funds are holding shares in ALNAQ
---
Company Description
Allena Pharmaceuticals
Allena Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company, which engages in the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes Reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults; and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease. The company was founded by Robert Gallotto and Alexey L. Margolin on June 24, 2011 and is headquartered in Newton, MA.
---
---